Feed your neurons ..
Good food in this blog.
A blog dedicated to recent developments in psychophysiology and clinical applications of ERP in neuropsychiatry. Ghent University Institute for Systems learning and Applied Neurophysiology.
31 juli 2008
Brain Stimulant: No B.S !
Deep brain TMS
30 juli 2008
New therapies for depression
Are the new Electromagnetic tools better then classical approaches to depression ?
They still broaden our therapeutic perspective and deserve to be considered in many cases.
Are they better then ECT ?
I put my money on rTMS but the new version by ANT with the Visor adaptation that incorporates neuronavigation and Robotmanipulation.
State of the art in neurodiagnostics and neurotherapeutics by ANT
Alzheimer: out of the (methyleen) Blue ???
And old remedy (methyleenblue) for an even older disease ? Sounds to good to be true but results of 18 month phase II are exciting !!
Maybe very good news but there are some caveat's to take into account. Read them here
29 juli 2008
IPEG
WELCOME TO THE 15TH IPEG MEETING ROUFFACH , FRANCE On behalf of the International Pharmaco-EEG Society (IPEG), I am pleased to invite you to the 15th biennial IPEG congress, which will take place in Rouffach, France on September 24-27, 2008.
The IPEG society is largely involved in promoting the use of electroencephalography (EEG) and related techniques in drug research from animal to clinic. Since the first EEG publications in the beginning of the 20th century, EEG discipline has known a continuous evolution. The most recent innovations of EEG are its use in multi-modal approaches to improve our knowledge of brain activity. The aim of the present IPEG meeting is to discuss the latest advances in research and issues regarding the use of EEG and EEG-related techniques in neurology, psychiatry, anesthesia and analgesia in a drug development perspective. Since interdisciplinary and international exchange can lead to a fruitful emergence of new ideas, experts and professionals from different countries and different disciplines across academia and industry will participate in this meeting. As previous IPEG congresses, the IPEG symposia will start with training courses designed to provide basic and advanced information on the different aspects of electroencephalography (EEG) / magnetoencephalography (MEG) research: principles, recording procedures, experimental designs, data analysis and interpretation, with applications in different fields of neuropsychopharmacology. We encourage all researchers, physicians and other professionals working with EEG to contribute to the success of the meeting by submitting abstracts for oral or poster presentations.
DBS for depression
My comment:
Although these results concerning area 25 DBS are truly encouraging, the fact that some patients do not seem to respond at all should make us wonder about a better search for more robust prediction and selection criteria. The problem is that once the electrodes are in place in the brain we cannot go back to ECT or rTMS (rapid transcranial magnetic stimulation). Although the first results of this rTMS procedure were not always consistently positive recent studies have shown that misalignment of the magnetic coil could often (40% errors) be held responsible for part of the outcome variance and this could be vastly improved pure technically by coupling the "old" rTMS stimulator to a genuine neuronavigation system cfr ANT EEG systems (http://www.ant-neuro.com/products/visor/) and even to a robot guided stimulation system. This makes it indeed more expensive but provides a much better stimulation robustness and quality especially in repetitive therapeutic stimulations. Pilot studies (fi at Univ Ulm, Germany ) have indeed shown very promising results in therapy resistent depression ! These results were presented in jan 2008 at the Neuromeeting Beaune France and will no doubt be further explored. Let us not forget that rTMS is a non invasive and non traumatic method in contrast to DBS that will always be limited to a small number of patients. As both the numbers of depressed patients and therapy resistent patients are huge, DBS will never be able to help them all.
PS A nice review on rTMS was published in Nature( Nature Reviews Neuroscience 8, (01 Oct 2007), doi: 10.1038/nrn2169-c2). So lets us help and support the DBS community but especially promote more vigorously the deployment of cornerstone studies on the therapeutic potency of the new ataumatic rTMS initiative especially in its new form that is in combination with robotica and neuronavigation.
Dr. G. Otte
28 juli 2008
Dimebon
An EEG dream come true ?
It 's an old dream to be able to cherry pick the best medications for our psychiatric patients suffering from diverse conditions, thus avoiding unwanted side effects and loss of precious time (and motivation, and adherence) in patients. We all look foreward to methods and biomarkers that would allow a more "personalised" clinical pharmacotherapy of overall better qualitative therapeutic results.
A a clinical neurophysiologist, without looking down on genetic markers or results of medical imaging, I was really hoping for our unintrusive and atraumatic neurophysiology techniques to be on the forefront of this endeavor.
That is exactly what the folks at CNS response are doing.
Check out their site ! hear others
Neurofeedback for Alzheimer: a study proposal
26 juli 2008
24 juli 2008
Uncle Joe's BCI
Question ?: Do these toy's really work as expected ? Not really.
As our friend Dieter DV from the Ghent BCI group points out: there is a lot of hype involved. Read about that here (in dutch)
23 juli 2008
Our bionic Kurtzweil future ?

Computers are becoming more powerful at an ever-increasing rate, butwill they ever become conscious? Artificial intelligence guru RayKurzweil thinks so and explains how we will "download" our software(our minds) and "upgrade" our hardware (our bodies) to become immortal-- before the dawn of the 22nd century. In this debate with hiscritics, including several Discovery Institute Fellows, Kurzweildefends his views and sets the stage for the central question: "Whatdoes it mean to be human?"
22 juli 2008
21 juli 2008
18 juli 2008
New anti Alzheimer drug ?
May 16, 2007 (Chicago, Illinois) — A largely forgotten antihistamine, first used in Russia more 30 years ago but shelved after newer, more targeted therapies came to market, is showing promise as a treatment for mild to moderate Alzheimer's disease (AD). Recently presented at the American Academy of Neurology 60th Annual Meeting, a 1-year randomized, placebo-controlled trial of the drug Dimebon (Medivation, San Francisco, CA) in 183 AD patients showed that individuals taking the drug experienced significant improvements in cognitive function, memory, ability to perform tasks of daily living, global function, and behavior. "One of the reassuring or hopeful findings from this study so far is that the drug/placebo differences were not driven just by a decline in the placebo group. The differences at 6 months from baseline [in patients in the active-treatment group] were statistically significant across all study measures, indicating that patients actually improved on the drug at 6 months," study investigator Rachelle Doody, MD, PhD, from Baylor College of Medicine, in Houston, Texas, told Medscape Neurology & Neurosurgery.
16 juli 2008
genetics and psychiatry: a complex relation

Geneticists know nothing about psychiatric disease.”
Daniel Weinberger
Finding genes involved in psychiatric conditions is proving to be particularly intractable because it is still unclear whether the various diagnoses are actually separate diseases with distinct underlying genetics or whether, as the DISC1 story suggests, they will dissolve under the genetic spotlight into one biological continuum. Indeed, some researchers suggest that it would be better to abandon conventional clinical definitions and focus instead on 'intermediate phenotypes', quantifiable characteristics such as brain structure, wiring and function that are midway between the risk genes involved and the psychopathology displayed.
14 juli 2008
InforMedix - The Medication Adherence Solution
InforMedix - The Medication Adherence Solution
Now from all gadgets this is really practical stuff ! take a look at the video (info commercial)
New Source of T-Rays | Popular Science
New Source of T-Rays | Popular Science
A new kid on the block with potential neuroscience ( brain imaging anyone) applications ? yet to be discovered...
PLoS Biology - Mapping the Structural Core of Human Cerebral Cortex
Mapping the human cortex. Think about what you see while seeing where You think.
PLoS Biology - Mapping the Structural Core of Human Cerebral Cortex
Eat less, drink more ... live longer ?
If GSK (they bought SIRTRIS) is asked, they will probably not say no.
Read on at their site, see the mouse running and while dreams are lingering on, do not forget to take a sip of that red burgundy, Chateau resveratrol. More info here

Now I realize why we are holding those Neuromeetings in Beaune :-)

13 juli 2008
Meet Igor Teper
The Gazzaniga Interview
Tom Wolfe + Michael Gazzaniga
Wolfe, who calls himself “the social secretary of neuroscience,” often turns to current research to inform his stories and cultural commentary. His 1996 essay, “Sorry, But Your Soul Just Died,” raised questions about personal responsibility in the age of genetic predeterminism. Similar concerns led Gazzaniga to found the Law and Neuroscience Project. When Gazzaniga, who just published Human: The Science Behind What Makes Us Unique, was last in New York, Seed incited a discussion: on status, free will, and the human condition.
Math is Music and Music is Math to the Brain
Roughly 2,500 years ago, Pythagoras observed that objects, such as the anvils he purportedly studied, produced harmonious sounds while vibrating at frequencies in simple whole-number ratios. More complex ratios gave rise to more dissonant sounds, which indicated that human beings were unconsciously sensitive to mathematical relationships inherent in nature. By showing that the world could be described mathematically, Pythagoras not only provided an important inspiration for physics, but he also discovered a particular affinity between mathematics and music--one that Gottfried Leibniz was to invoke centuries later when he described music as the "unknowing exercise of our mathematical faculties." Read on in SEED
Big BANG..bang....bang....BANG
How did the universe begin? Did it have a beginning at all?
These questions may have been the subject of speculation and debate for millennia, but they have not been widely discussed for the past forty years. Ever since the discovery of the cosmic background radiation in 1965, the overwhelmingly predominant view has been that our universe began about 14 billion years ago in a cosmic fireball known as the "big bang" and that it has been expanding, cooling, and evolving ever since.
Recently, though, a small but growing number of theorists have begun to challenge this conventional belief and to pursue a radical new history of the universe. According to this new idea, there was a big bang, but this was not the beginning of space and time. In fact, in the version proposed by Neil Turok.......... Read on
10 juli 2008
(H) i Human
What happened along the evolutionary trail that made humans sounique? In his widely accessible style, Michael Gazzaniga looks to a broad range of studies to pinpoint the change that made us thinking,sentient humans, different from our predecessors. Neuroscience has been fixated on the life of the psychological self for the past fifty years, focusing on the brain systems underlying language, memory, emotion, and perception. What it has not done consider the stark reality that most of the time we humans are thinking is about social processes, comparing ourselves to and estimating the intentions of others. In Human,Gazzaniga explores a number of related issues, including what makes human brains unique, the importance of language and art in defining the human condition, the nature of human consciousness, and even artificial intelligence.understand the human condition by examining the biological, psychological, and highly social nature of our species within the social context of our lives
Dopamine for Dummies
Developing Intelligence : Dopamine for Dummies
This is really a great blog on Cognitive Neurosciences. Subjects on attention, meditation modulated attentional resource activation, attention focus and memory, prospective memory and many more..enjoy.
09 juli 2008
08 juli 2008
At the blink of an eye you should decide to buy this book

Better Than Conscious? Decision Making, the Human Mind, and Implications For Institutions Edited by Christoph Engel and Wolf Singer
Conscious control enables human decision makers to override routines, to exercise willpower, to find innovative solutions, to learn by instruction, to decide collectively, and to justify their choices. These and many more advantages, however, come at a price: the ability to process information consciously is severely limited and conscious decision makers are liable to hundreds of biases. Measured against the norms of rational choice theory, conscious decision makers perform poorly. But if people forgo conscious control, in appropriate tasks, they perform surprisingly better: they handle vast amounts of information; they update prior information; they find appropriate solutions to ill-defined problems.
07 juli 2008
Brain & Cognition: The Holland synapse
You have to admit that our friends from the netherlands puttheir money on the right horses. Brain and Cognition are no doubt the right breed to "head" the future of Cognitive neuropsychiatry and neurophysiology. As they plan to start international scientific expert meeting cores they endorse our leading life motto: "Cooperation beats competition".let's get together.
06 juli 2008
Are You aware of this website ?
CAM machines
05 juli 2008
Here be Dragons
03 juli 2008
Brodmann GPS
If You ever want to navigate Brodmann country (and who would not ?) equip yourself well. Take this map (and surf the website first). Can be downloaded in .xls format. Happy travelling.
related links:
Terra Cognita
Brainworld: blog
Toronto add centre (infocommercial)



















